Lexicon Pharmaceuticals | LXRX - Ebitda



金融业
股票价格
USD 1.86
资产
USD 268.82M
现金及等价物
USD 38.09M
销售成本
USD 201K
流动资产
USD 186.03M
流动负债
USD 9.9M
债务
USD 99.51M
股息收益率
0
EBIT
USD -14.78M
EBITDA
USD -12.04M
员工
285
EPS每股收益
USD -0.04
股本和储备
USD 202.86M
销售毛利
USD 5.29M
债务利息支出
USD 2.03M
贷款资金
USD 49.68M
市值
USD 438.3M
净收入
USD -15.53M
营业费用
USD 20.27M
营业利润
USD -14.78M
普通股股本
USD 363.47M
PE价格收益
12.44
税前利润
USD -12.77M
销售收入
USD 5.49M
销售和管理费用
USD 3.99M
股票
USD 276K
贸易债权人
USD 3M
应收帐款人
USD 2.38M


Ebitda 更改 日
Abbott USD 2.43B 844M 2026-03
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 9.46B 3.54B 2026-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Illumina USD 330M 80M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 8.99B 721M 2026-06
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD -64.54M 34.34M 2026-06
MannKind USD 2.47M 461K 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -687M 571M 2026-06
Novartis USD 8.62B 2.14B 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
United Therapeutics USD 334.2M 20.8M 2026-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12